![]() Half of patients with advanced non-small cell lung cancer with MET exon 14 skipping mutations responded to the targeted agent ABN401, including six of eight patients with previously untreated disease, Abion announced. Preclinical studies suggested that combining the cholesterol-lowering drug lovastatin with a HER2-targeted antibody-drug conjugate may reduce the number of treatment cycles required for HER2-expressing cancers. ![]() A phase III trial of neoadjuvant therapy with the immunocytokine daromun met the primary endpoint of recurrence-free survival in fully resectable locally advanced melanoma, Philogen and Sun Pharma announced.Ī single injection of the HSV-1 oncolytic immunotherapy CAN-3110 led to a median overall survival of 11.6 months in recurrent high-grade glioma.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |